DSGN vs HAL · $214.0M cap vs P/E 9.3, $19.05B cap
Design Therapeutics Inc (DSGN) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
HAL does not have a complete income-statement cache yet.
DSGN currently screens at market cap $214.0M. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the DSGN and HAL stock pages for the full models.
Not investment advice.